About us
Metabrain Research was created as a PRO to get the best out of top-of-the-range preclinical research facilities combined with the imagination of a biotech start-up. Indeed the management’s history of metabolic disease research and drug discovery has nurtured unique know-how that feeds our corporate vision.
Our partnering research organization is designed to help drug and nutraceutic developers live up to the challenges they face, through contract research & research collaborations.
History
Our research centre has been involved in metabolic disorder research for decades. It was part of company that developed the first anti-diabetic blockbuster, metformin. Our premises received heavy investments until 2007 and we have restarted expanding our technical capacities in 2010.
PRO vision
Metabrain’s corporate identity as a Partnering Research Organisation is based on two converging ambitions :
- Transform the connections between metabolic and neurodegenerative diseases into innovative drugs
- Achieve this through original partnerships involving the industry, biotech & academia.
Understand the difference a PRO makes...
Management Team
Our management team integrates award-winning chemists, metabolic disease experts and managers with a proven track record of drug discovery & development.